Recommendations from the findings by the RCGP oral contraception study on the mortality risks of oral contraceptive users.
نویسندگان
چکیده
It has been shown [in the research results published in the Lancet on 8 October] in the RCGP study population that oral contraceptive users compared with non-users have an increased risk of 1 per 5000 per year of dying from cardiovascular disease. This risk is concentrated, however, in women over the age of 35 years, especially if they smoke cigarettes and have used oral contraceptives continuously for five years or more. This relationship to duration of use requires confirmation. These observations in the study will permit clinicians to identify women at special risk more accurately than before. There is no evidence to suggest that the risk for most women under the age of 35 years is great enough to warrant any change in clinical practice unless the well-known additional risk factors of cardiovascular disease are present. The division of the data at age 35 is arbitrary and it would be prudent to assume that there is a gradually increasing risk at an earlier age. These are the considerations on which we have based our recommendations. Recommendations WOMEN UNDER 30 YEARS OF AGE We have no evidence to justify recommending any change of practice. It would be wise to emphasise the general advantage of stopping smoking. Because we have to assume a gradually increasing risk up to 35 years of age, we suggest that some women over 30 years ought to reconsider their use of oral contraceptives. We believe that women in this age group who have used oral contraceptives continuously for more than five years and who are cigarette smokers should come into this category. If they would stop smoking it would probably be reasonable for them to continue the pill. If not, it might be wiser for them to change to another method. Because of the obvious confidentiality of this issue, we have not been able to consult our respective Councils. These recommendations therefore represent the personal opinions of the above named. WOMEN OVER 35 YEARS There may well be circumstances where women over the age of 35 years would accept the additional risks involved and would wish to continue oral contraceptives. However, in general it would be wise for all oral contraceptive users over 35 years of age to reconsider their method of contraception. Older women who smoke and/or have used oral contraceptives continuously for more than five years may well have extra risks which they and their …
منابع مشابه
Comparison of cause of death coding on death certificates with coding in the Royal College of General Practitioners Oral Contraception Study.
A comparison has been made between the coding of the cause of death by (a) the Royal College of General Practitioners (RCGP) during the Oral Contraception Study and (b) the Office of Population Censuses and Surveys (OPCS) or the General Register Office for Scotland (GRO) on death certificates for the same subjects. Broad grouping of the International Classification of Diseases (ICD) showed clos...
متن کاملMortality among contraceptive pill users: cohort evidence from Royal College of General Practitioners’ Oral Contraception Study
OBJECTIVE To see if the mortality risk among women who have used oral contraceptives differs from that of never users. DESIGN Prospective cohort study started in 1968 with mortality data supplied by participating general practitioners, National Health Service central registries, or both. SETTING 1400 general practices throughout the United Kingdom. PARTICIPANTS 46 112 women observed for u...
متن کاملعوارض قلبی عروقی قرصهای ضد بارداری خوراکی
SUMMARY Cardiovascular complication of oral contraceptives Mohammad Reza Afraz M.D. cardiologist Assistant professor, Gilan university of medical sciences, Rasht. Soon after the introduction of oral contraceptive agents in 1960, the potential risks of cardiovascular disease became apparent. Most investigators agree that there is an increased incidence of hypertension, myocardial infarction, c...
متن کاملOral contraception and eye disease: findings in two large cohort studies.
The relationship between oral contraceptive (OC) use and eye disease was investigated through abstraction of salient data from the two large British cohort studies of the effects of OCs: the Royal College of General Practitioners' (RCGP) OC Study and the Oxford-Family Planning Association (FPA) Contraception Study. Together, these studies have accumulated over 850,000 person-years of observati...
متن کاملCancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioner's oral contraception study.
OBJECTIVE To examine the absolute risks or benefits on cancer associated with oral contraception, using incident data. DESIGN Inception cohort study. SETTING Royal College of General Practitioners' oral contraception study. PARTICIPANTS Directly standardised data from the Royal College of General Practitioners' oral contraception study. MAIN OUTCOME MEASURES Adjusted relative risks betw...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- British medical journal
دوره 2 6092 شماره
صفحات -
تاریخ انتشار 1977